StockMacro
Menu

Pfizer

$27.40 +6.0% in 6 monthsMarket cap $156.2B

PFE on XNYS, Health Care, Pfizer Inc., job postings

Measures activity, not value. Not investment advice.

Net income fell 59% to $4B over 12 months while quarterly revenue slipped 0.4% to $16.6B.

  • WatchShares down 8.2% in one month but up 12% over 12 months

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 27 Sep 2026

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

Industry
Pharmaceutical preparations (Health Care)
Employees
75,000
Website
pfizer.com
Listed
NYSE, US
Last results
3 Nov 2026
Next results
expected around 2 Feb 2027 (an estimate: a year ago it reported on 3 Feb 2026)
Revenue and net income per quarter. Quarter to 27 Sep 2026: revenue $16.6B, net income $3.2B.
Quarter to 3 Apr 2022: revenue $25.7B, net income $7.9BQuarter to 3 Apr 2022: revenue $25.7B, net income $7.9BQuarter to 3 Jul 2022: revenue $27.7B, net income $9.9BQuarter to 3 Jul 2022: revenue $27.7B, net income $9.9BQuarter to 2 Oct 2022: revenue $22.6B, net income $8.6BQuarter to 2 Oct 2022: revenue $22.6B, net income $8.6BQuarter to 31 Dec 2022: revenue $24.3B, net income –Quarter to 2 Apr 2023: revenue $18.3B, net income $5.5BQuarter to 2 Apr 2023: revenue $18.3B, net income $5.5BQuarter to 2 Jul 2023: revenue $12.7B, net income $2.3BQuarter to 2 Jul 2023: revenue $12.7B, net income $2.3BQuarter to 1 Oct 2023: revenue $13.2B, net income -$2.4BQuarter to 1 Oct 2023: revenue $13.2B, net income -$2.4BQuarter to 31 Dec 2023: revenue $14.2B, net income -$3.4BQuarter to 31 Dec 2023: revenue $14.2B, net income -$3.4BQuarter to 31 Mar 2024: revenue $14.9B, net income $3.1BQuarter to 31 Mar 2024: revenue $14.9B, net income $3.1BQuarter to 30 Jun 2024: revenue $13.3B, net income $41.0MQuarter to 30 Jun 2024: revenue $13.3B, net income $41.0MQuarter to 29 Sep 2024: revenue $17.7B, net income $4.5BQuarter to 29 Sep 2024: revenue $17.7B, net income $4.5BQuarter to 31 Dec 2024: revenue –, net income $410.0MQuarter to 30 Mar 2025: revenue $13.7B, net income $3.0BQuarter to 30 Mar 2025: revenue $13.7B, net income $3.0BQuarter to 29 Jun 2025: revenue $14.7B, net income $2.9BQuarter to 29 Jun 2025: revenue $14.7B, net income $2.9BQuarter to 28 Sep 2025: revenue $16.7B, net income $3.5BQuarter to 28 Sep 2025: revenue $16.7B, net income $3.5BQuarter to 31 Dec 2025: revenue –, net income -$1.6BQuarter to 29 Mar 2026: revenue $14.5B, net income $2.7BQuarter to 29 Mar 2026: revenue $14.5B, net income $2.7BQuarter to 28 Jun 2026: revenue $15.0B, net income -$248.0MQuarter to 28 Jun 2026: revenue $15.0B, net income -$248.0MQuarter to 27 Sep 2026: revenue $16.6B, net income $3.2BQuarter to 27 Sep 2026: revenue $16.6B, net income $3.2B
3 Apr 2022RevenueNet incomeNet losstallest bar $27.7B27 Sep 2026
See the numbers
Quarter toRevenueNet income
27 Sep 2026$16.6B$3.2B
28 Jun 2026$15.0B-$248.0M
29 Mar 2026$14.5B$2.7B
31 Dec 2025–-$1.6B
28 Sep 2025$16.7B$3.5B
29 Jun 2025$14.7B$2.9B
30 Mar 2025$13.7B$3.0B
31 Dec 2024–$410.0M
29 Sep 2024$17.7B$4.5B
30 Jun 2024$13.3B$41.0M
31 Mar 2024$14.9B$3.1B
31 Dec 2023$14.2B-$3.4B
1 Oct 2023$13.2B-$2.4B
2 Jul 2023$12.7B$2.3B
2 Apr 2023$18.3B$5.5B
31 Dec 2022$24.3B–
2 Oct 2022$22.6B$8.6B
3 Jul 2022$27.7B$9.9B
3 Apr 2022$25.7B$7.9B
Fundamentals, 12 months to 27 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $63.6B $62.8B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +1.3% +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $4.0B $9.8B
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $0.70 $1.72
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 73.4% 73.4% 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 6.3% 15.7% -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 4.4% -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $11.8B $10.4B
CashCash, cash equivalents and short-term investments on the latest balance sheet. $10.9B $11.5B
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $62.7B $61.7B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $51.7B $50.2B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.70 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $15.61
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 38.7 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. 2.5 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 3.3 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.8 2.0
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 6.3% 2.5%

Latest = 12 months to 27 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
PfizerPFE (this company) $156.2B38.72.5+1.3%6.3%
Abbott LaboratoriesABT $178.4B37.93.7+10%9.7%
Vertex PharmaceuticalsVRTX $130.6B32.810.1+10%30.7%
Bristol-Myers SquibbBMY $120.2B13.02.4+4.2%18.5%
Regeneron PharmaceuticalsREGN $95.2B19.85.6+19%28.5%
MerckMRK $329.7B1344.9+4.9%3.6%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+3.7%

2,878 13F filers vs 2,774

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

66%

3.8B shares held by 13F filers (30 Sep 2026) of 5.7B outstanding (28 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

2.4%

134.4M shares sold short (30 Oct 2026) of 5.7B outstanding (28 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.6

134.4M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-2.5%

137.8M shares sold short in the report before, 134.4M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

34%

34% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 43%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

-40%

49 vs 81 applications

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

-0.4%

$16.6B vs $16.7B (quarter ended 27 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-4.8%

$573.0M vs $602.0M (quarter ended 27 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$11.7M

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

108

108 articles in the last 7 days; its usual week has 11.5 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

9.4×

108 articles in the last 7 days; its usual week has 11.5.

Price $27.40 on 20 Nov 2026, +12% over 12 months (12-month range $23.67 to $30.79)

  • Sharp change
  • 8-K and other filings
  • WARN layoff notice
  • Lobbying filing
Insider net buying (open market). Insiders bought a net $2.8M in the last 12 months (the 12 months before: $434K).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 49 published in the last 12 months, -40% on the 12 months before.
Revenue per quarter. Revenue $16.6B in the latest quarter, -0.4% on a year earlier.
Capital spending per quarter. Capital spending $573.0M in the latest quarter, -4.8% on a year earlier.
Institutional holders (13F filers). 2,878 13F filers reported holding it in the latest 13F quarter, +7.7% on a year earlier.
Federal obligations. Federal obligations: -$1.3M published in the last 12 months, -147% on the 12 months before.
Lobbying spend. Lobbying spend: $18.3M published in the last 12 months, +213% on the 12 months before.
Workers in WARN layoff notices. Workers in WARN layoff notices: 0 published in the last 12 months.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
3 Nov 20268-K and other filingsDirector or officer change
3 Nov 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
13 Aug 2026Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 3.0M)
14 Jul 2026Sharp changeWikipedia attention spike: wikipedia attention spike, 11K vs usual 5,563.50 (2026-07-06..2026-07-12); 1.6x the same week a year earlier
18 Jun 20268-K and other filingsDirector or officer change
18 Jun 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
17 Mar 2026Sharp changeLobbying on a new issue: lobbying on a new issue: TAR (2025-06-30)
16 Oct 2025Lobbying filingnew lobbying registration (RESOLUTION PUBLIC AFFAIRS, LLC)
7 Oct 2025Sharp changeWikipedia attention spike: wikipedia attention spike, 19K vs usual 7,407.50 (2025-09-29..2025-10-05); 2.2x the same week a year earlier
29 Apr 20258-K and other filingsRestructuring costs announced
21 Apr 2025Lobbying filinglobbying engagement terminated (AVOQ, LLC)
21 Apr 2025Lobbying filinglobbying engagement terminated (SHOOK, HARDY & BACON, LLP)
22 Jan 2025Lobbying filinglobbying engagement terminated (CORNERSTONE GOVERNMENT AFFAIRS, INC.)
20 Jan 2025Lobbying filinglobbying engagement terminated (NVG, LLC)
17 Dec 2024Sharp changeShort interest spike: short interest spike, 90.4M vs usual 63.8M (2024-11-29); 1.6x the same period a year earlier
3 Dec 2024Sharp changeShort interest spike: short interest spike, 94.5M vs usual 62.3M (2024-11-15); 1.6x the same period a year earlier
15 Oct 20248-K and other filingsDirector or officer change
20 Aug 2024Sharp changeMany funds opening a new position: many funds opening a new position, 165 vs usual 92 (2024-06-30); 1.9x the same period a year earlier
26 Jul 20248-K and other filingsDirector or officer change
18 Jul 2024Lobbying filinglobbying engagement terminated (ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC))
10 Jul 20248-K and other filingsDirector or officer change
1 Jul 20248-K and other filingsDirector or officer change
1 Jul 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
22 May 20248-K and other filingsRestructuring costs announced
21 May 2024Sharp changeMany funds opening a new position: many funds opening a new position, 131 vs usual 92 (2024-03-31); 1.6x the same period a year earlier
23 Apr 2024Lobbying filinglobbying engagement terminated (TODD STRATEGY GROUP)
20 Feb 2024Sharp changeWikipedia attention spike: wikipedia attention spike, 18K vs usual 11K (2024-02-12..2024-02-18); 1.6x the same week a year earlier
22 Jan 2024Lobbying filinglobbying engagement terminated (THEGROUP DC, LLC)
22 Jan 2024Lobbying filinglobbying engagement terminated (HARBINGER STRATEGIES, LLC)
21 Jan 2024Lobbying filinglobbying engagement terminated (CGCN GROUP, LLC)
21 Jan 2024Lobbying filinglobbying engagement terminated (OGR)
12 Dec 20238-K and other filingsDirector or officer change
12 Dec 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
1 Nov 2023WARN layoff noticePfizer Inc, 195 workers, Gladstone, NJ
1 Nov 2023Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 195)
26 Oct 2023Lobbying filingnew lobbying registration (TODD STRATEGY GROUP)
13 Oct 20238-K and other filingsRestructuring costs announced
6 Oct 2023Sharp changeFirst award from a new federal agency: first award from a new federal agency (Department of State): MERIDIAN MEDICAL TECHNOLOGIES, LLC: new Department of State contract 19AQMM23F3176 ($17,955,752)
27 Jul 20238-K and other filingsDirector or officer change
27 Jul 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
26 Jul 2023WARN layoff noticePfizer Inc., 69 workers, Lake Forest, IL
26 Jul 2023Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 69)
20 Jul 2023Lobbying filinglobbying engagement terminated (THE RABEN GROUP)
18 Jul 2023Lobbying filinglobbying engagement terminated (RUTLEDGE POLICY GROUP, LLC)
21 Apr 2023Lobbying filinglobbying engagement terminated (BLUE STAR STRATEGIES LLC)
18 Apr 2023Lobbying filingnew lobbying registration (HARBINGER STRATEGIES, LLC)
11 Apr 2023Lobbying filinglobbying engagement terminated (NVG, LLC)
6 Apr 2023Lobbying filingnew lobbying registration (CGCN GROUP, LLC)
24 Jan 2023Sharp changeWikipedia attention spike: wikipedia attention spike, 14K vs usual 9,157.50 (2023-01-16..2023-01-22); 0.5x the same week a year earlier
20 Jan 2023Lobbying filinglobbying engagement terminated (EMPIRE CONSULTING GROUP)
20 Jan 2023Lobbying filinglobbying engagement terminated (W STRATEGIES, LLC)
19 Jan 2023Lobbying filinglobbying engagement terminated (in-house)
16 Aug 2022Sharp changeQuarterly revenue change: quarterly revenue change, 27.7B vs usual 13.6B (2022-07-03); 1.5x the same period a year earlier
10 Jul 2022Lobbying filingnew lobbying registration (RUTLEDGE POLICY GROUP, LLC)
17 May 2022Sharp changeQuarterly revenue change: quarterly revenue change, 25.7B vs usual 12.7B (2022-04-03); 1.8x the same period a year earlier
12 Apr 20228-K and other filingsDirector or officer change
12 Apr 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 Feb 2022Sharp changeMany funds opening a new position: many funds opening a new position, 233 vs usual 111.50 (2021-12-31); 2.6x the same period a year earlier
15 Dec 20218-K and other filingsDirector or officer change
6 Dec 2021Lobbying filingnew lobbying registration (BLUE STAR STRATEGIES LLC)
Insider net buying (open market)
Month from 1 Dec 2021: -$7.8M published
Month from 1 May 2022: -$7.0M published
Month from 1 Jun 2022: -$228K published
Month from 1 Mar 2023: -$397K published
Month from 1 May 2023: $77K published
Month from 1 Dec 2023: $79K published
Month from 1 Aug 2024: -$148K published
Month from 1 Nov 2024: $28K published
Month from 1 Feb 2025: $499K published
Month from 1 Mar 2025: -$65K published
Month from 1 Jun 2026: -$51K published
Month from 1 Aug 2026: $2.9M published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 12 published
Quarter from 1 Apr 2022: 12 published
Quarter from 1 Jul 2022: 30 published
Quarter from 1 Oct 2022: 9 published
Quarter from 1 Jan 2023: 5 published
Quarter from 1 Apr 2023: 3 published
Quarter from 1 Jul 2023: 21 published
Quarter from 1 Oct 2023: 20 published
Quarter from 1 Jan 2024: 7 published
Quarter from 1 Apr 2024: 14 published
Quarter from 1 Jul 2024: 36 published
Quarter from 1 Oct 2024: 17 published
Quarter from 1 Jan 2025: 19 published
Quarter from 1 Apr 2025: 15 published
Quarter from 1 Jul 2025: 40 published
Quarter from 1 Oct 2025: 7 published
Quarter from 1 Jan 2026: 10 published
Quarter from 1 Apr 2026: 5 published
Quarter from 1 Jul 2026: 25 published
Quarter from 1 Oct 2026: 9 published
Revenue per quarter
Quarter ended 3 Apr 2022: $25.7B, +76% on a year earlier; public on 12 May 2022
Quarter ended 3 Jul 2022: $27.7B, +46% on a year earlier; public on 11 Aug 2022
Quarter ended 2 Oct 2022: $22.6B, -6.0% on a year earlier; public on 10 Nov 2022
Quarter ended 31 Dec 2022: $24.3B; public on 24 Feb 2023
Quarter ended 2 Apr 2023: $18.3B, -29% on a year earlier; public on 11 May 2023
Quarter ended 2 Jul 2023: $12.7B, -54% on a year earlier; public on 10 Aug 2023
Quarter ended 1 Oct 2023: $13.2B, -42% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $14.2B, -41% on a year earlier; public on 23 Feb 2024
Quarter ended 31 Mar 2024: $14.9B, -19% on a year earlier; public on 9 May 2024
Quarter ended 30 Jun 2024: $13.3B, +4.3% on a year earlier; public on 6 Aug 2024
Quarter ended 29 Sep 2024: $17.7B, +34% on a year earlier; public on 5 Nov 2024
Quarter ended 30 Mar 2025: $13.7B, -7.8% on a year earlier; public on 6 May 2025
Quarter ended 29 Jun 2025: $14.7B, +10% on a year earlier; public on 6 Aug 2025
Quarter ended 28 Sep 2025: $16.7B, -5.9% on a year earlier; public on 5 Nov 2025
Quarter ended 29 Mar 2026: $14.5B, +5.4% on a year earlier; public on 6 May 2026
Quarter ended 28 Jun 2026: $15.0B, +2.6% on a year earlier; public on 5 Aug 2026
Quarter ended 27 Sep 2026: $16.6B, -0.4% on a year earlier; public on 4 Nov 2026
Capital spending per quarter
Quarter ended 3 Apr 2022: $643.0M, +16% on a year earlier; public on 12 May 2022
Quarter ended 3 Jul 2022: $751.0M; public on 11 Aug 2022
Quarter ended 2 Apr 2023: $1.1B, +77% on a year earlier; public on 11 May 2023
Quarter ended 2 Jul 2023: $914.0M, +22% on a year earlier; public on 10 Aug 2023
Quarter ended 1 Oct 2023: $810.0M; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $1.0B; public on 23 Feb 2024
Quarter ended 31 Mar 2024: $704.0M, -38% on a year earlier; public on 9 May 2024
Quarter ended 30 Jun 2024: $637.0M, -30% on a year earlier; public on 6 Aug 2024
Quarter ended 29 Sep 2024: $651.0M, -20% on a year earlier; public on 5 Nov 2024
Quarter ended 31 Dec 2024: $917.0M, -12% on a year earlier; public on 28 Feb 2025
Quarter ended 30 Mar 2025: $564.0M, -20% on a year earlier; public on 6 May 2025
Quarter ended 29 Jun 2025: $618.0M, -3.0% on a year earlier; public on 6 Aug 2025
Quarter ended 28 Sep 2025: $602.0M, -7.5% on a year earlier; public on 5 Nov 2025
Quarter ended 31 Dec 2025: $845.0M, -7.9% on a year earlier; public on 27 Feb 2026
Quarter ended 29 Mar 2026: $436.0M, -23% on a year earlier; public on 6 May 2026
Quarter ended 28 Jun 2026: $533.0M, -14% on a year earlier; public on 5 Aug 2026
Quarter ended 27 Sep 2026: $573.0M, -4.8% on a year earlier; public on 4 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 2,870; public on 14 Feb 2022
31 Mar 2022 report: 2,985; public on 16 May 2022
30 Jun 2022 report: 2,958; public on 15 Aug 2022
30 Sep 2022 report: 2,822; public on 14 Nov 2022
31 Dec 2022 report: 2,968; public on 14 Feb 2023
31 Mar 2023 report: 2,887; public on 15 May 2023
30 Jun 2023 report: 2,795; public on 14 Aug 2023
30 Sep 2023 report: 2,695; public on 14 Nov 2023
31 Dec 2023 report: 2,698; public on 14 Feb 2024
31 Mar 2024 report: 2,705; public on 15 May 2024
30 Jun 2024 report: 2,705; public on 14 Aug 2024
30 Sep 2024 report: 2,732; public on 14 Nov 2024
31 Dec 2024 report: 2,786; public on 14 Feb 2025
31 Mar 2025 report: 2,781; public on 15 May 2025
30 Jun 2025 report: 2,666; public on 14 Aug 2025
30 Sep 2025 report: 2,672; public on 14 Nov 2025
31 Dec 2025 report: 2,783; public on 17 Feb 2026
31 Mar 2026 report: 2,851; public on 15 May 2026
30 Jun 2026 report: 2,774; public on 14 Aug 2026
30 Sep 2026 report: 2,878; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $726K published
Month from 1 Dec 2021: $861.2M published
Month from 1 Jan 2022: $1.2B published
Month from 1 Feb 2022: $6.8B published
Month from 1 Mar 2022: $14K published
Month from 1 Apr 2022: $2.5B published
Month from 1 May 2022: $8K published
Month from 1 Jun 2022: $755K published
Month from 1 Jul 2022: -$2.3M published
Month from 1 Aug 2022: $10K published
Month from 1 Sep 2022: $3.2B published
Month from 1 Oct 2022: $481K published
Month from 1 Nov 2022: -$1.9B published
Month from 1 Dec 2022: $4.9B published
Month from 1 Jan 2023: $5K published
Month from 1 Feb 2023: $2K published
Month from 1 Mar 2023: $1.9B published
Month from 1 Apr 2023: -$2K published
Month from 1 May 2023: $30.0M published
Month from 1 Jun 2023: $101K published
Month from 1 Jul 2023: -$9.3M published
Month from 1 Aug 2023: $843K published
Month from 1 Sep 2023: -$24.7M published
Month from 1 Oct 2023: $18.0M published
Month from 1 Nov 2023: $769K published
Month from 1 Dec 2023: -$15K published
Month from 1 Jan 2024: $213K published
Month from 1 Feb 2024: $115K published
Month from 1 Mar 2024: -$42K published
Month from 1 Apr 2024: -$1K published
Month from 1 May 2024: -$19.5M published
Month from 1 Jun 2024: -$462 published
Month from 1 Jul 2024: $14K published
Month from 1 Aug 2024: -$3.8M published
Month from 1 Sep 2024: $419K published
Month from 1 Oct 2024: $2.4M published
Month from 1 Nov 2024: -$8.5M published
Month from 1 Dec 2024: $99K published
Month from 1 Jan 2025: $4K published
Month from 1 Feb 2025: $6K published
Month from 1 Mar 2025: $16K published
Month from 1 Apr 2025: $6K published
Month from 1 May 2025: $1.3M published
Month from 1 Jun 2025: $8K published
Month from 1 Jul 2025: -$26K published
Month from 1 Aug 2025: $13K published
Month from 1 Sep 2025: $39K published
Month from 1 Oct 2025: $474K published
Month from 1 Nov 2025: $820K published
Month from 1 Dec 2025: -$1.2M published
Month from 1 Jan 2026: $13K published
Month from 1 Feb 2026: $7K published
Month from 1 Mar 2026: $11K published
Month from 1 Apr 2026: $56K published
Month from 1 May 2026: $41K published
Month from 1 Jun 2026: $30K published
Month from 1 Jul 2026: $75K published
Month from 1 Aug 2026: -$374K published
Month from 1 Sep 2026: $10K published
Month from 1 Oct 2026: $22K published
Month from 1 Nov 2026: $1K published
Lobbying spend
Quarter from 1 Jan 2022: $3.1M published
Quarter from 1 Apr 2022: $3.1M published
Quarter from 1 Jul 2022: $2.7M published
Quarter from 1 Oct 2022: $3.5M published
Quarter from 1 Jan 2023: $3.3M published
Quarter from 1 Apr 2023: $4.6M published
Quarter from 1 Jul 2023: $2.5M published
Quarter from 1 Oct 2023: $4.0M published
Quarter from 1 Jan 2024: $3.0M published
Quarter from 1 Apr 2024: $3.7M published
Quarter from 1 Jul 2024: $2.5M published
Quarter from 1 Oct 2024: $1.1M published
Quarter from 1 Jan 2025: $1.6M published
Quarter from 1 Apr 2025: $4.2M published
Quarter from 1 Jan 2026: $8.4M published
Quarter from 1 Apr 2026: $4.4M published
Quarter from 1 Jul 2026: $1.9M published
Quarter from 1 Oct 2026: $3.6M published
Workers in WARN layoff notices
Month from 1 Jul 2023: 69 published
Month from 1 Nov 2023: 195 published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $1.0M (12 Aug 2026), higher than 99% of its own history. Two or more unrelated kinds of activity agreed on 13 Aug 2026.
  • Wikipedia attention spike: drew 11K Wikipedia page views in the week of 6 Jul 2026, 1.6× the same week last year Public on 14 Jul 2026.
  • Clustered insider buying: had 3 insiders buy $3.0M of its shares on the open market within 30 days (3 filings) Public on 13 Aug 2026.
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 49 published in the last 12 months, -40% on the 12 months before.

Latest records

The names and amounts behind the totals, newest first

No trades in the last 90 days; the latest was filed 12 Aug 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
12 Aug 2026Albert BourlaChairman & CEOBuy38,000$26.34$1.0MForm 4
6 Aug 2026Jennifer B. DamicoSVP & ControllerSell3,278$25.40$83KForm 4
5 Aug 2026Mortimer J BuckleyDirectorBuy37,632$25.52$960KForm 4
5 Aug 2026Ronald E BlaylockDirectorBuy39,231$25.46$999KForm 4
10 Jun 2026Jennifer B. DamicoSVP & ControllerSell2,000$25.70$51KForm 4
6 Mar 2025Jennifer B. DamicoSVP & ControllerSell2,500$25.93$65KForm 4
14 Feb 2025Ronald E BlaylockDirectorBuy19,457$25.65$499KForm 4
31 Oct 2024Scott GottliebDirectorBuy1,000$28.24$28KForm 4

2,878 institutions reported shares at the end of Q3 2026, 66% of the shares outstanding; 222 opened a position, 121 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.521.0M9.14%$14.9B-8.6M-1.6%
Vanguard Capital Management LLC373.0M6.54%$10.6B+853K+0.2%
State Street Corp309.6M5.43%$8.8B+2.5M+0.8%
Geode Capital Management, LLC137.5M2.41%$3.9B+2.2M+1.6%
Vanguard Portfolio Management LLC120.5M2.11%$3.4B+1.2M+1.0%
Fisher Asset Management, LLC112.1M1.97%$3.2B+3.1M+2.8%
Morgan Stanley96.9M1.70%$2.8B+586K+0.6%
Massachusetts Financial Services Co64.6M1.13%$1.9B+8.1M+14%
Northern Trust Corp58.9M1.03%$1.7B-183K-0.3%
State Farm Mutual Automobile Insurance Co54.5M0.96%$1.6BNo change

Federal contracts

All 63 federal contracts

No new award in 12 months; the latest was signed 13 Feb 2025. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
13 Feb 2025Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response$1.2MSTERILE WATER FOR INJECTION 20MLUSAspending
30 Sep 2024Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response$2.2MTHE PURPOSE OF THIS DELIVERY ORDER IS TO PROCURE PHARMACEUTICALS TO REPLENISH EXPIRED PRODUCT.USAspending
30 Sep 2023Department of State$18.0MAUTOINJECTORS AND TRAINERSUSAspending
22 Sep 2023Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response$9.9MPURCHASE DUODOTE SINGLE DOSE AUTOINJECTORS - EMERGENCY PROCUREMENT.USAspending
29 Jun 2022Department of DefenseDepartment of the Army$4.0Bup to $23.0BCOVID-19 ADULT MDV VACCINEUSAspending
17 Nov 2021Department of DefenseDepartment of the Army$12.5BAWARD OF 10M TREATMENT COURSES OF ORAL PROTEASE INHIBITOR PF-07321332USAspending
30 Jul 2021Department of DefenseDepartment of the Army$4.9BCOVID-19 VACCINES FOR INTERNATIONAL DONATIONUSAspending
1 Jul 2021Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response$1.2MSTERILE WATER 20ML INJECTIONSUSAspending

Company events

All 37 company events

In 12 months: 2 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
3 Nov 2026Director or officer change8-K
18 Jun 2026Director or officer change8-K
29 Apr 2025Restructuring costs announced8-K
15 Oct 2024Director or officer change8-K
26 Jul 2024Director or officer change8-K
10 Jul 2024Director or officer change8-K
1 Jul 2024Director or officer change8-K
22 May 2024Restructuring costs announced8-K

Reported lobbying spend: $3.6M in Q3 2026, $1.9M in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Aug 2025NewResolution Public Affairs, LLCfor PfizerIssues impacting Rx development and sales, generallyHealth issuesFiling
31 Jan 2025EndedAvoq, LLCfor Pfizer, Inc.General health issuesHealth issuesFiling
1 Jan 2025EndedShook, Hardy & Bacon, LLPfor PfizerNot statedFiling
31 Dec 2024EndedCornerstone Government Affairs, Inc.for PfizerSupport increased funding for the CDC National Immunization Program (Sec 317 program).; Support increased funding for the CDC National Immunization Program (Sec 317 program)Budget, Health issuesFiling
31 Dec 2024EndedNVG, LLCfor Pfizer Inc.Intellectual property, data exclusivity, and patent eligibility.; 340B legislation. Issues related to vaccine injury compensation funds. S.2115/H.R.4307 - Medical Supply Chain Resiliency Act.Copyright/patents, Health issuesFiling
6 May 2024EndedRoberti Global (F/K/A Roberti White, LLC)for Pfizer Inc.Not statedFiling
31 Dec 2023EndedTodd Strategy Groupfor Pfizer Inc.General Medicare / Medicaid Issues Implementation of Inflation Reduction Act of 2022. Medicare coverage of Anti-Obesity Medications.; Pharmacy Benefit Managers.Medicare/Medicaid, PharmacyFiling
31 Dec 2023EndedThegroup DC, LLCfor Pfizer, Inc.General health care policy and biopharmaceutical manufacturing issues. Provisions related to prescription drugs. Issues related to promoting access to COVID oral antiviral drug.Health issuesFiling

Layoff notices

All 9 layoff notices

No notice in 12 months; the latest is dated 1 Oct 2023. State WARN notices.

NoticeSiteWorkersJobs endSource
1 Oct 2023Pfizer IncGladstone, NJ19512 Feb 2024Notice
25 Jul 2023Pfizer Inc.Lake County, IL6925 Sep 2023layoffNotice
17 Jun 2010Hospira, Inc.Lake County, IL3001 Apr 2009closureNotice
28 Apr 2010Hospira, Inc.Lake County, IL5141 Nov 2008layoffNotice
1 Dec 2009PFIZERMONMOUTH JUNCTION, NJ40031 Jan 2010Notice
1 Jan 2009King PharmaceuticalsBridgewater, NJ7129 Mar 2009Notice
12 Sep 2008Hospira, Inc.Lake County, IL1681 Mar 2008closureNotice
1 Oct 2007KING PHARMACEUTICALSWAYNE/POMPTON PLNS, NJ1528 Dec 2007Notice

The 5 newest of 1,003 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

13 Aug 2026confirmed

Confirmed across sources Attention and Insiders

Pfizer (PFE): drew 11K Wikipedia page views in the week of 6 Jul 2026, 1.6× the same week last year, while it had 3 insiders buy $3.0M of its shares on the open market within 30 days (3 filings). Two unrelated kinds of activity within 29 days.

  • Attention: Wikipedia attention spike, became public on 14 Jul 2026
  • Insiders: Clustered insider buying, became public on 13 Aug 2026
2026-01-05: 6,5182026-01-12: 7,2532026-01-19: 8,1092026-01-26: 6,2782026-02-02: 6,6802026-02-09: 6,9062026-02-16: 6,1362026-02-23: 5,7422026-03-02: 5,5432026-03-09: 5,7932026-03-16: 5,4282026-03-23: 5,5652026-03-30: 6,2792026-04-06: 5,4682026-04-13: 5,6022026-04-20: 5,4062026-04-27: 5,3242026-05-04: 6,0542026-05-11: 5,5622026-05-18: 5,0152026-05-25: 5,1442026-06-01: 4,8442026-06-08: 4,7302026-06-15: 5,5132026-06-22: 4,3992026-06-29: 4,3402026-07-06: 11K
The week of 6 Jul 2026 against the 26 weeks before it. this weekearliernormal: 5,564
See the evidence (2 changes)

Attention: Wikipedia attention spike became public on 14 Jul 2026

Pfizer drew 11K Wikipedia page views in the week of 6 Jul 2026, 1.6× the same week last year.

This period
11K (the week of 6 Jul 2026)
Normal week (median of 26 earlier)
5,564
Typical spread (median absolute deviation)
520
How far from its usual level
+6.4
Same week last year
6,642
History used
2,749 days
2026-01-05: 6,5182026-01-12: 7,2532026-01-19: 8,1092026-01-26: 6,2782026-02-02: 6,6802026-02-09: 6,9062026-02-16: 6,1362026-02-23: 5,7422026-03-02: 5,5432026-03-09: 5,7932026-03-16: 5,4282026-03-23: 5,5652026-03-30: 6,2792026-04-06: 5,4682026-04-13: 5,6022026-04-20: 5,4062026-04-27: 5,3242026-05-04: 6,0542026-05-11: 5,5622026-05-18: 5,0152026-05-25: 5,1442026-06-01: 4,8442026-06-08: 4,7302026-06-15: 5,5132026-06-22: 4,3992026-06-29: 4,3402026-07-06: 11K
the week of 6 Jul 202626 earlier weeksnormal: 5,564

Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

Check it at the source: Wikimedia page view statistics.

Insiders: Clustered insider buying became public on 13 Aug 2026

Pfizer had 3 insiders buy $3.0M of its shares on the open market within 30 days (3 filings).

Independent buyers
3
Purchase filings (Form 4, code P)
3
Total bought
$3.0M
Window
14 Jul 2026 to 13 Aug 2026

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

1 Nov 2023confirmed

Confirmed across sources Government contracts and Layoff notices

Pfizer (PFE): won its first award from the Department of State, a $18.0M contract, after 60 earlier federal awards from other agencies, while it filed a WARN layoff notice covering 195 workers within 30 days (Gladstone, NJ). Two unrelated kinds of activity within 26 days.

  • Government contracts: First award from a new federal agency, became public on 6 Oct 2023
  • Layoff notices: WARN layoff notice, became public on 1 Nov 2023
See the evidence (2 changes)

Government contracts: First award from a new federal agency became public on 6 Oct 2023

Pfizer won its first award from the Department of State, a $18.0M contract, after 60 earlier federal awards from other agencies.

Source coverage starts
7 Oct 2007
Earlier events of other kinds
60

"First" means first in our data: it fires only when the source's history began at least 365 days earlier.

Layoff notices: WARN layoff notice became public on 1 Nov 2023

Pfizer filed a WARN layoff notice covering 195 workers within 30 days (Gladstone, NJ).

Notices in the window
1
Workers named
195
Window
2 Oct 2023 to 1 Nov 2023

Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

17 Nov 2020confirmed

Confirmed across sources Attention and Institutional holdings

Pfizer (PFE): saw 143 13F filers open a new position in the quarter ended 30 Sep 2020, 1.9× the same quarter last year, while it drew 709K Wikipedia page views in the week of 9 Nov 2020, 65× the same week last year. Two unrelated kinds of activity on the same day.

  • Institutional holdings: Many funds opening a new position, became public on 16 Nov 2020
  • Attention: Wikipedia attention spike, became public on 17 Nov 2020
2018-09-30: 982018-12-31: 612019-03-31: 812019-06-30: 722019-09-30: 752019-12-31: 732020-03-31: 952020-06-30: 1182020-09-30: 143
The quarter ended 30 Sep 2020 against the 8 quarters before it. this quarterearliernormal: 78
See the evidence (2 changes)

Institutional holdings: Many funds opening a new position became public on 16 Nov 2020

Pfizer saw 143 13F filers open a new position in the quarter ended 30 Sep 2020, 1.9× the same quarter last year.

This period
143 (the quarter ended 30 Sep 2020)
Normal quarter (median of 8 earlier)
78
Typical spread (median absolute deviation)
11.5
How far from its usual level
+3.8
Same quarter last year
75
History used
2,557 days
2018-09-30: 982018-12-31: 612019-03-31: 812019-06-30: 722019-09-30: 752019-12-31: 732020-03-31: 952020-06-30: 1182020-09-30: 143
the quarter ended 30 Sep 20208 earlier quartersnormal: 78

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Attention: Wikipedia attention spike became public on 17 Nov 2020

Pfizer drew 709K Wikipedia page views in the week of 9 Nov 2020, 65× the same week last year.

This period
709K (the week of 9 Nov 2020)
Normal week (median of 26 earlier)
13K
Typical spread (median absolute deviation)
1,752
How far from its usual level
+268.0
Same week last year
11K
History used
684 days
2020-05-11: 15K2020-05-18: 13K2020-05-25: 13K2020-06-01: 11K2020-06-08: 10K2020-06-15: 10K2020-06-22: 9,1902020-06-29: 16K2020-07-06: 11K2020-07-13: 13K2020-07-20: 48K2020-07-27: 19K2020-08-03: 13K2020-08-10: 11K2020-08-17: 10K2020-08-24: 11K2020-08-31: 12K2020-09-07: 23K2020-09-14: 19K2020-09-21: 11K2020-09-28: 12K2020-10-05: 13K2020-10-12: 19K2020-10-19: 18K2020-10-26: 14K2020-11-02: 12K2020-11-09: 709K
the week of 9 Nov 202026 earlier weeksnormal: 13K

Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

Check it at the source: Wikimedia page view statistics.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 3 Nov 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  2. 3 Nov 2026Filings record

    Director or officer change

  3. 13 Aug 2026several at once

    drew 11K Wikipedia page views in the week of 6 Jul 2026, 1.6× the same week last year, while it had 3 insiders buy $3.0M of its shares on the open market within 30 days (3 filings). Two unrelated kinds of activity within 29 days.

    See the evidence (2 changes)

    Attention: Wikipedia attention spike became public on 14 Jul 2026

    Pfizer drew 11K Wikipedia page views in the week of 6 Jul 2026, 1.6× the same week last year.

    This period
    11K (the week of 6 Jul 2026)
    Normal week (median of 26 earlier)
    5,564
    Typical spread (median absolute deviation)
    520
    How far from its usual level
    +6.4
    Same week last year
    6,642
    History used
    2,749 days
    2026-01-05: 6,5182026-01-12: 7,2532026-01-19: 8,1092026-01-26: 6,2782026-02-02: 6,6802026-02-09: 6,9062026-02-16: 6,1362026-02-23: 5,7422026-03-02: 5,5432026-03-09: 5,7932026-03-16: 5,4282026-03-23: 5,5652026-03-30: 6,2792026-04-06: 5,4682026-04-13: 5,6022026-04-20: 5,4062026-04-27: 5,3242026-05-04: 6,0542026-05-11: 5,5622026-05-18: 5,0152026-05-25: 5,1442026-06-01: 4,8442026-06-08: 4,7302026-06-15: 5,5132026-06-22: 4,3992026-06-29: 4,3402026-07-06: 11K
    the week of 6 Jul 202626 earlier weeksnormal: 5,564

    Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

    Check it at the source: Wikimedia page view statistics.

    Insiders: Clustered insider buying became public on 13 Aug 2026

    Pfizer had 3 insiders buy $3.0M of its shares on the open market within 30 days (3 filings).

    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $3.0M
    Window
    14 Jul 2026 to 13 Aug 2026

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  4. 13 Aug 2026Insiders change

    had 3 insiders buy $3.0M of its shares on the open market within 30 days (3 filings).

    Who bought: Blaylock Ronald E, Buckley Mortimer J, Bourla Albert.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $3.0M
    Window
    14 Jul 2026 to 13 Aug 2026

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  5. 13 Aug 2026Insiders record

    BOURLA ALBERT (Chairman & CEO) bought 38,000 shares of PFE ($1.0M) (dated 12 Aug 2026)

  6. 6 Aug 2026Insiders record

    Buckley Mortimer J (director) bought 37,632 shares of PFE ($960,369) (dated 5 Aug 2026)

  7. 6 Aug 2026Insiders record

    BLAYLOCK RONALD E (director) bought 39,231 shares of PFE ($998,821) (dated 5 Aug 2026)

  8. 14 Jul 2026Attention change

    drew 11K Wikipedia page views in the week of 6 Jul 2026, 1.6× the same week last year.

    Same week last year: 6,642; its normal week is 5,564.

    See the evidence
    This period
    11K (the week of 6 Jul 2026)
    Normal week (median of 26 earlier)
    5,564
    Typical spread (median absolute deviation)
    520
    How far from its usual level
    +6.4
    Same week last year
    6,642
    History used
    2,749 days
    2026-01-05: 6,5182026-01-12: 7,2532026-01-19: 8,1092026-01-26: 6,2782026-02-02: 6,6802026-02-09: 6,9062026-02-16: 6,1362026-02-23: 5,7422026-03-02: 5,5432026-03-09: 5,7932026-03-16: 5,4282026-03-23: 5,5652026-03-30: 6,2792026-04-06: 5,4682026-04-13: 5,6022026-04-20: 5,4062026-04-27: 5,3242026-05-04: 6,0542026-05-11: 5,5622026-05-18: 5,0152026-05-25: 5,1442026-06-01: 4,8442026-06-08: 4,7302026-06-15: 5,5132026-06-22: 4,3992026-06-29: 4,3402026-07-06: 11K
    the week of 6 Jul 202626 earlier weeksnormal: 5,564

    Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

    Check it at the source: Wikimedia page view statistics.

  9. 18 Jun 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  10. 18 Jun 2026Filings record

    Director or officer change

  11. 17 Mar 2026Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['TAR']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    4837098
  12. 16 Oct 2025Lobbying record

    PFIZER: new lobbying registration (RESOLUTION PUBLIC AFFAIRS, LLC) (dated 1 Aug 2025)

  13. 7 Oct 2025Attention change

    drew 19K Wikipedia page views in the week of 29 Sep 2025, 2.2× the same week last year.

    Same week last year: 8,683; its normal week is 7,408.

    See the evidence
    This period
    19K (the week of 29 Sep 2025)
    Normal week (median of 26 earlier)
    7,408
    Typical spread (median absolute deviation)
    846
    How far from its usual level
    +9.2
    Same week last year
    8,683
    History used
    2,469 days
    2025-03-31: 8,4922025-04-07: 8,8172025-04-14: 8,9192025-04-21: 7,2782025-04-28: 7,7142025-05-05: 7,8672025-05-12: 8,9022025-05-19: 7,3642025-05-26: 7,4642025-06-02: 6,8122025-06-09: 6,2822025-06-16: 6,1012025-06-23: 6,0452025-06-30: 5,6752025-07-07: 6,6422025-07-14: 6,4812025-07-21: 6,4722025-07-28: 6,9272025-08-04: 7,5922025-08-11: 7,0852025-08-18: 7,0622025-08-25: 7,5982025-09-01: 9,6222025-09-08: 8,3992025-09-15: 7,4512025-09-22: 9,7952025-09-29: 19K
    the week of 29 Sep 202526 earlier weeksnormal: 7,408

    Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

    Check it at the source: Wikimedia page view statistics.

  14. 15 May 2025Institutional holdings record

    Qube Research & Technologies Ltd opened a $271.0M position (2025Q1 13F)

  15. 14 May 2025Institutional holdings record

    ARROWSTREET CAPITAL, LIMITED PARTNERSHIP opened a $331.0M position (2025Q1 13F)

  16. 29 Apr 2025Filings record

    Restructuring costs announced

  17. 21 Apr 2025Lobbying record

    PFIZER, INC.: lobbying engagement terminated (AVOQ, LLC) (dated 31 Jan 2025)

  18. 21 Apr 2025Lobbying record

    PFIZER: lobbying engagement terminated (SHOOK, HARDY & BACON, LLP) (dated 1 Jan 2025)

  19. 19 Feb 2025Government contracts record

    PFIZER INC: new Department of Health and Human Services contract 75A50325F63003 ($1.2M) (dated 13 Feb 2025)

  20. 15 Feb 2025Insiders record

    BLAYLOCK RONALD E (director) bought 19,457 shares of PFE ($499,072) (dated 14 Feb 2025)

  21. 22 Jan 2025Lobbying record

    PFIZER: lobbying engagement terminated (CORNERSTONE GOVERNMENT AFFAIRS, INC.) (dated 31 Dec 2024)

  22. 20 Jan 2025Lobbying record

    PFIZER INC.: lobbying engagement terminated (NVG, LLC) (dated 31 Dec 2024)

  23. 11 Dec 2024Short interest and volume change

    had 90.4M shares sold short in the 29 Nov 2024 report, 1.6× the same report last year.

    Same report last year: 56.9M; its normal report is 63.8M.

    See the evidence
    This period
    90.4M (the 29 Nov 2024 report)
    Normal report (median of 24 earlier)
    63.8M
    Typical spread (median absolute deviation)
    3.9M
    How far from its usual level
    +4.2
    Same report last year
    56.9M
    History used
    2,527 days
    2023-11-30: 56.9M2023-12-15: 61.9M2023-12-29: 57.0M2024-01-12: 57.6M2024-01-31: 60.2M2024-02-15: 60.7M2024-02-29: 66.1M2024-03-15: 71.7M2024-03-28: 65.0M2024-04-15: 68.1M2024-04-30: 62.5M2024-05-15: 70.2M2024-05-31: 76.0M2024-06-14: 62.1M2024-06-28: 59.9M2024-07-15: 55.7M2024-07-31: 65.3M2024-08-15: 61.7M2024-08-30: 65.4M2024-09-13: 74.8M2024-09-30: 67.6M2024-10-15: 70.9M2024-10-31: 61.9M2024-11-15: 94.5M2024-11-29: 90.4M
    the 29 Nov 2024 report24 earlier reportsnormal: 63.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 27 Nov 2024Short interest and volume change

    had 94.5M shares sold short in the 15 Nov 2024 report, 1.6× the same report last year.

    Same report last year: 57.5M; its normal report is 62.3M.

    See the evidence
    This period
    94.5M (the 15 Nov 2024 report)
    Normal report (median of 24 earlier)
    62.3M
    Typical spread (median absolute deviation)
    4.3M
    How far from its usual level
    +5.1
    Same report last year
    57.5M
    History used
    2,513 days
    2023-11-15: 57.5M2023-11-30: 56.9M2023-12-15: 61.9M2023-12-29: 57.0M2024-01-12: 57.6M2024-01-31: 60.2M2024-02-15: 60.7M2024-02-29: 66.1M2024-03-15: 71.7M2024-03-28: 65.0M2024-04-15: 68.1M2024-04-30: 62.5M2024-05-15: 70.2M2024-05-31: 76.0M2024-06-14: 62.1M2024-06-28: 59.9M2024-07-15: 55.7M2024-07-31: 65.3M2024-08-15: 61.7M2024-08-30: 65.4M2024-09-13: 74.8M2024-09-30: 67.6M2024-10-15: 70.9M2024-10-31: 61.9M2024-11-15: 94.5M
    the 15 Nov 2024 report24 earlier reportsnormal: 62.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 1 Nov 2024Insiders record

    Gottlieb Scott (director) bought 1,000 shares of PFE ($28,240) (dated 31 Oct 2024)

  26. 15 Oct 2024Filings record

    Director or officer change

  27. 6 Oct 2024Government contracts record

    PFIZER INC: new Department of Health and Human Services contract 75A50324F80014 ($2.2M) (dated 30 Sep 2024)

  28. 14 Aug 2024Institutional holdings change

    saw 165 13F filers open a new position in the quarter ended 30 Jun 2024, 1.9× the same quarter last year.

    Same quarter last year: 87; its normal quarter is 92.

    See the evidence
    This period
    165 (the quarter ended 30 Jun 2024)
    Normal quarter (median of 8 earlier)
    92
    Typical spread (median absolute deviation)
    11
    How far from its usual level
    +4.5
    Same quarter last year
    87
    History used
    3,926 days
    2022-06-30: 912022-09-30: 932022-12-31: 1342023-03-31: 822023-06-30: 872023-09-30: 772023-12-31: 1042024-03-31: 1312024-06-30: 165
    the quarter ended 30 Jun 20248 earlier quartersnormal: 92

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  29. 26 Jul 2024Filings record

    Director or officer change

  30. 18 Jul 2024Lobbying record

    PFIZER INC.: lobbying engagement terminated (ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)) (dated 6 May 2024)

  31. 10 Jul 2024Filings record

    Director or officer change

  32. 1 Jul 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  33. 1 Jul 2024Filings record

    Director or officer change

  34. 22 May 2024Filings record

    Restructuring costs announced

  35. 15 May 2024Institutional holdings change

    saw 131 13F filers open a new position in the quarter ended 31 Mar 2024, 1.6× the same quarter last year.

    Same quarter last year: 82; its normal quarter is 92.

    See the evidence
    This period
    131 (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    92
    Typical spread (median absolute deviation)
    7.5
    How far from its usual level
    +3.5
    Same quarter last year
    82
    History used
    3,835 days
    2022-03-31: 962022-06-30: 912022-09-30: 932022-12-31: 1342023-03-31: 822023-06-30: 872023-09-30: 772023-12-31: 1042024-03-31: 131
    the quarter ended 31 Mar 20248 earlier quartersnormal: 92

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  36. 23 Apr 2024Lobbying record

    PFIZER INC.: lobbying engagement terminated (TODD STRATEGY GROUP) (dated 31 Dec 2023)

  37. 20 Feb 2024Attention change

    drew 18K Wikipedia page views in the week of 12 Feb 2024, 1.6× the same week last year.

    Same week last year: 11K; its normal week is 11K.

    See the evidence
    This period
    18K (the week of 12 Feb 2024)
    Normal week (median of 26 earlier)
    11K
    Typical spread (median absolute deviation)
    558
    How far from its usual level
    +6.9
    Same week last year
    11K
    History used
    1,874 days
    2023-08-14: 11K2023-08-21: 11K2023-08-28: 10K2023-09-04: 10K2023-09-11: 11K2023-09-18: 11K2023-09-25: 11K2023-10-02: 12K2023-10-09: 11K2023-10-16: 12K2023-10-23: 11K2023-10-30: 11K2023-11-06: 10K2023-11-13: 11K2023-11-20: 11K2023-11-27: 12K2023-12-04: 12K2023-12-11: 13K2023-12-18: 11K2023-12-25: 10K2024-01-01: 10K2024-01-08: 11K2024-01-15: 12K2024-01-22: 12K2024-01-29: 13K2024-02-05: 12K2024-02-12: 18K
    the week of 12 Feb 202426 earlier weeksnormal: 11K

    Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

    Check it at the source: Wikimedia page view statistics.

  38. 22 Jan 2024Lobbying record

    PFIZER, INC.: lobbying engagement terminated (THEGROUP DC, LLC) (dated 31 Dec 2023)

  39. 22 Jan 2024Lobbying record

    PFIZER INC.: lobbying engagement terminated (HARBINGER STRATEGIES, LLC) (dated 31 Dec 2023)

  40. 21 Jan 2024Lobbying record

    PFIZER, INC.: lobbying engagement terminated (CGCN GROUP, LLC) (dated 31 Dec 2023)

Showing the newest 40 of 163 entries; narrow the window or the kind of data to see older ones.

Not listed: 233 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000078003
Ticker
PFE
Domain
pfizer.com
Employer name
KING PHARMACEUTICALS, PFIZER INC. (2 unverified)
Hq location
NY|NEW YORK|10001 (1 unverified)
Lobbying client
global blood therapeutics, pfizer, pfizer australia
Name
356 Royalty Inc, Agouron Pharmaceuticals, LLC, AHP Manufacturing B.V, AH Robins LLC and 257 more
Uei
DP7KL2MKRSB5, MHBQULRMEEJ5
Wikidata
Q206921
Wikipedia
Pfizer
  • DOL H-1B labor condition applications and PERM certifications961 data points1 Oct 2019 to 28 Sep 2026
  • Federal lobbying disclosures (LDA)168 records, 278 data points1 Jan 1999 to 30 Sep 2026
  • SEC Form 13F institutional holdings14 records, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)172 records2 Feb 2016 to 3 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1218 data points31 Dec 2006 to 28 Oct 2026
  • SEC Form 4 insider transactions104 records, 292 data points5 May 2016 to 12 Aug 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards63 records, 10211 data points1 Oct 2007 to 14 Aug 2026
  • WARN layoff notices (state labor agencies)9 records, 27 data points28 Nov 2005 to 1 Oct 2023
  • Wikipedia pageviews2881 data points1 Jan 2019 to 20 Nov 2026